
A gene known to control lens development is also vital for the development of neurons responsible for touch sensation, scientists have found.
Neurobiologists of the Max Delbruck Center for Molecular Medicine (MDC) Berlin-Buch found that in mice in which they had removed the c-Maf gene in the nerve cells, touch sensation is impaired.
Advertisement
This similarly applies to human carriers of a mutant c-Maf gene. People with such a mutation suffer already at a young age from cataracts, a clouding of the lens, which typically affects the elderly.
The patients, as demonstrated by Professor Carmen Birchmeier and Dr. Hagen Wende in collaboration with Professor Gary Lewin and Dr. Stefan Lechner, have difficulty holding objects such as a sheet of paper as a consequence of this mutation.
"c-Maf is an important gene for the development of the peripheral nerve cells," Professor Birchmeier, a developmental biologist, commented on the findings of her research group.
The gene controls the development of neurons that detect touch, the mechanosensory neurons. Previously, c-Maf was known as a key regulator of lens development.
Furthermore, the gene is also active in the dorsal root ganglia, an aggregate of nerve cells next to the spinal cord in which the cell bodies of mechanosensory neurons are localized.
The nerve cells form long axons, which terminate in the skin in touch corpuscles or at hair shafts.
These axons detect mechanical stimuli, which in turn are converted into electrical signals and transmitted to the brain. When you stroke your fingers over a surface, its structure triggers high-frequency vibrations in the finger, to which specific touch receptors, the Pacinian corpuscles, respond.
In mice with deactivated c-Maf gene only few Pacinian corpuscles are formed, and moreover these few are not intact.
The mice are therefore unable to recognize high-frequency vibrations. The same is true for a Swiss family with an inherited mutant c-Maf gene.
The consequence is that the affected patients develop cataracts at an early age and have an impaired sense of touch.
Source: ANI
Advertisement
"c-Maf is an important gene for the development of the peripheral nerve cells," Professor Birchmeier, a developmental biologist, commented on the findings of her research group.
The gene controls the development of neurons that detect touch, the mechanosensory neurons. Previously, c-Maf was known as a key regulator of lens development.
Furthermore, the gene is also active in the dorsal root ganglia, an aggregate of nerve cells next to the spinal cord in which the cell bodies of mechanosensory neurons are localized.
The nerve cells form long axons, which terminate in the skin in touch corpuscles or at hair shafts.
These axons detect mechanical stimuli, which in turn are converted into electrical signals and transmitted to the brain. When you stroke your fingers over a surface, its structure triggers high-frequency vibrations in the finger, to which specific touch receptors, the Pacinian corpuscles, respond.
In mice with deactivated c-Maf gene only few Pacinian corpuscles are formed, and moreover these few are not intact.
The mice are therefore unable to recognize high-frequency vibrations. The same is true for a Swiss family with an inherited mutant c-Maf gene.
The consequence is that the affected patients develop cataracts at an early age and have an impaired sense of touch.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News

Scientists have developed the first humanized mouse model for a rare hereditary condition.

A recent study discovered that the placenta, rather than only the brain, is crucial in determining the genetic risk of schizophrenia.

FOXI3 gene was found to be involved in Goldenhar syndrome, one form of developmental disorder, revealed research.

Contrary to previous beliefs, genes may not be fixed and can be influenced by environmental factors and lifestyle choices, according to modern scientific research.

Gene therapy successfully tested on dogs with inherited eye disease is now poised for clinical use in humans.